Silvia Vai

ORCID: 0000-0002-6981-5561
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Bone health and osteoporosis research
  • Neurogenetic and Muscular Disorders Research
  • Liver Disease Diagnosis and Treatment
  • Nutrition and Health in Aging
  • Bone health and treatments
  • Body Composition Measurement Techniques
  • Congenital Anomalies and Fetal Surgery
  • Childhood Cancer Survivors' Quality of Life
  • Medical Imaging and Pathology Studies
  • Parathyroid Disorders and Treatments
  • Bone and Joint Diseases
  • Neuroblastoma Research and Treatments
  • Osteomyelitis and Bone Disorders Research
  • Cerebral Palsy and Movement Disorders
  • Biochemical and Molecular Research
  • Adenosine and Purinergic Signaling
  • Liver Diseases and Immunity
  • Alkaline Phosphatase Research Studies
  • Hepatitis B Virus Studies
  • Glycogen Storage Diseases and Myoclonus
  • Neurological disorders and treatments
  • Aldose Reductase and Taurine
  • Cancer Diagnosis and Treatment
  • Vitamin D Research Studies

IRCCS Istituto Auxologico Italiano
2010-2024

Istituti di Ricovero e Cura a Carattere Scientifico
2007-2022

Medical University of Lodz
2007

San Raffaele University of Rome
1998

Vita-Salute San Raffaele University
1997

Epidemiological studies support the hypothesis that genetic factors modulate risk for diabetic nephropathy (DN). Aldose reductase (ALDR1), rate-limiting enzyme in polyol pathway, is a potential candidate gene. The present study explores polymorphisms of (A-C)n dinucleotide repeat sequence, located 2.1 kb upstream transcription start site, ALDR1 gene expression and DN. We conducted at two different institutions, University New Mexico Health Sciences Center (UNMHSC), Istituto Scientifico H San...

10.1210/jcem.83.8.5028 article EN The Journal of Clinical Endocrinology & Metabolism 1998-08-01

The ability of low-intensity vibration (LIV) to combat skeletal decline in Duchenne Muscular Dystrophy (DMD) was evaluated a randomized controlled trial. Twenty DMD boys were enrolled, all ambulant and treated with glucocorticoids (mean age 7.6, height-adjusted Z-scores [HAZ] hip bone mineral density [BMD] -2.3). Ten assigned stand for 10 min/d on an active LIV platform (0.4 g at 30 Hz), while stood placebo device. Baseline 14-month content (BMC) BMD spine, hip, total body measured DXA,...

10.1002/jbm4.10685 article EN cc-by JBMR Plus 2022-09-25

Glycogen storage disease (GSD) is the most prevalent inherited disorder of glycogen metabolism for which no causal treatment available. In recent years, thanks to improved clinical management, life expectancy these patients extended, disclosing previously unidentified adverse conditions in other organs. this study, we evaluated bone complications and cellular responses 20 (aged 14.1 ± 3.4 years) affected by GSD type I. Fragility fractures were reported 35% patients, older than unfractured...

10.1007/s00223-024-01302-4 article EN cc-by-nc-nd Calcified Tissue International 2024-10-25

Adenosine Deaminase 2 Deficiency (DADA2) syndrome is a rare monogenic disorder prevalently linked to recessive inherited loss of function mutations in the

10.3390/ijms22158331 article EN International Journal of Molecular Sciences 2021-08-03

Searchable abstracts of presentations at key conferences on calcified tissues ISSN 2052-1219 (online)

10.1530/boneabs.5.oc5.6 article EN Bone Abstracts 2016-04-21

Searchable abstracts of presentations at key conferences on calcified tissues ISSN 2052-1219 (online)

10.1530/boneabs.5.p482 article EN Bone Abstracts 2016-04-21
Coming Soon ...